The process begins with collecting T cells from the patient’s blood. These T cells are then genetically modified in a laboratory to express the CAR, which allows them to target specific antigens present on cancer cells. After being expanded in number, the [modified T cells](https://) are infused back into the patient, where they seek out and destroy cancer cells.
